Sight Sciences, Inc. SGHT
8.93
0.25
2.88%
as of 25 Sep
- Market cap
- $478.2M
- P/E
- 0.0×
Follow SGHT
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(57.91%) | (50.74%) | (56.64%) | (48.42%) | |
| (35.49%) | (29.77%) | (31.12%) | (26.24%) | ||
ROIC |
(236.53%) | (188.86%) | (235.20%) | (125.18%) | |
Return on Tangible Assets |
(44.63%) | (37.19%) | (41.41%) | (36.02%) | |
Average Days of Receivables |
46.76 | 45.98 | 48.61 | 49.84 | |
Free Cash Flow per Share |
(0.61) | (0.58) | (0.47) | (0.43) | |
Free Cash Flow |
(31.89) | (30.05) | (25.40) | (23.33) | |
Capital Expenditures |
(0.57) | (0.36) | (0.28) | (0.09) | |
Piotroski F-Score |
3.00 | 5.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(15.92%) | (15.13%) | (14.00%) | (13.40%) | |
Accounts Receivable Turnover |
6.71 | 7.54 | 7.95 | 7.94 | |
Accounts Payable Turnover |
6.98 | 7.05 | 5.18 | 5.05 | |
Inventory Turnover |
1.51 | 1.52 | 1.72 | 1.69 | |
Average Days of Payables |
59.91 | 45.83 | 49.29 | 69.00 | |
Days of Inventory on Hand |
274.58 | 265.02 | 232.44 | 207.04 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
21.65% | 18.88% | 15.99% | 13.01% | |
Selling, General and Administrative Expense of Revenue |
124.04% | 115.25% | 114.99% | 108.38% | |
Share Based Compensation of Revenue |
19.00% | 16.87% | 14.66% | 12.94% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.68 | 0.77 | 0.67 | 0.78 | |
Depreciation/Fixed assets |
0.95 | 0.89 | 0.86 | 0.82 | |
Capex/Depreciation |
(0.39) | (0.25) | (0.20) | (0.07) | |
Revenue per Share |
1.45 | 1.48 | 1.47 | 1.53 | |
Operating CF per Share |
(0.60) | (0.57) | (0.47) | (0.43) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(60.63%) | (49.67%) | (46.83%) | (35.69%) |
Columns are period end dates